GÜMÜŞ, MAHMUTIsikdogan, A.Turk, H.Bilir, C.Sendur, M.Karabulut, B.Artac, M.Cicin, I.Geredeli, C.Alacacioglu, A.Kefeli, U.Harputluoglu, H.Bozkurt, O.Cubukcu, E.Tural, D.Sakin, A.Cil, T.Dane, F.Cevik, D.Arslan, C.Karadurmus, N.YALÇIN, SIDDIKA SONGÜL2022-08-202022-08-202022-06-01Isikdogan A., Turk H., Bilir C., Sendur M., Karabulut B., Artac M., Cicin I., Geredeli C., Alacacioglu A., Kefeli U., et al., -First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon Turkey study subgroup analysis-, ANNALS OF ONCOLOGY, cilt.33, 2022http://hdl.handle.net/20.500.12645/30868ArticleWOS:00082382650010310.1016/j.annonc.2022.04.180